SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-24-004489
Filing Date
2024-08-06
Accepted
2024-08-06 16:38:41
Documents
16
Effectiveness Date
2024-08-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 fs8_062724.htm S-8 47767
2 EXHIBIT 5.1 exh_51.htm EX-5.1 8702
3 EXHIBIT 23.1 exh_231.htm EX-23.1 2631
4 FILING FEE IXBRL exh_107.htm   iXBRL EX-FILING FEES 12615
5 GRAPHIC gibsonlogo.jpg GRAPHIC 3999
  Complete submission text file 0001171843-24-004489.txt   204468

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT exh_107_htm.xml XML 4627
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281294 | Film No.: 241179988
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)